Alberta Investment Management Corp Bio Rad Laboratories, Inc. Transaction History

Alberta Investment Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$304.11 - $351.99 $364,932 - $422,388	1,200 New	1,200 $415,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $251,214 - $301,800	600 New	600 $287,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $3.86 Million - $4.97 Million	-8,324 Reduced 79.38%	2,162 $1.07 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $3.24 Million - $4.55 Million	6,186 Added 143.86%	10,486 $5.91 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $2.48 Million - $2.79 Million	4,300 New	4,300 $2.77 Million
Q1 2021 May 07, 2021	SELL	$547.01 - $662.35 $1.7 Million - $2.05 Million	-3,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $1.58 Million - $1.99 Million	3,100 New	3,100 $1.81 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.